home   |   contact us   |   sitemap     

 
   about Formula Pharmaceuticals  technology  pipeline NewsCareers  
   
   
             
   
Top News


Media Contact  

 

 


 

 

 

 

TOP NEWS

September 18, 2017
Formula Pharmaceuticals Announces Initiation of the First Clinical Trial for Allogeneic CIK-CAR Cancer Immunotherapy


May 05, 2016
Formula Pharmaceuticals appoints Malcolm K. Brenner, MD, PhD to its Scientific Advisory Board


February 22, 2016
Formula Pharmaceuticals and Rockland Immunochemicals Enter Into a Collaboration To Develop C.I.K. CAR™ Immunotherapy Pipeline for the Treatment of Cancer
DOWNLOAD PDF


August 13, 2015
Formula Pharmaceuticals establishes Scientific Advisory Board with Leading Experts in support of Chimeric Antigen Receptor immunotherapy platform involving Cytokine Induced Killer cells

August 03, 2015
Formula Pharmaceuticals and the Max Delbrück Center for Molecular Medicine Enter Into an Exclusive Licensing Agreement and Strategic Collaboration to Develop C.I.K. CAR™ Immunotherapies


May 12, 2015
Formula Pharmaceuticals featured in BioWorld Today
"Formula One: CAR-CIK to make queasy riders of others in T-cell race?"
 DOWNLOAD PDF





May 11, 2015
Formula Pharmaceuticals Acquires Next-Generation, Allogeneic, Non-Viral Chimeric Antigen Receptor (CAR) Immunotherapy Platform; Completes Private Fundraising


March 4, 2014
Formula Pharmaceuticals featured in premier investor opinion and analysis website, Seeking Alpha
DOWNLOAD PDF





October 1, 2013
Pilot clinical trial of FPI-01 initiated in patients with Multiple Myeloma following autologous stem cell transplantation


June 4, 2012
Formula Pharmaceuticals Appoints Morton Collins to Board of Directors


January 24, 2012
Formula Pharmaceuticals Appoints Martyn Greenacre to Board of Directors


December 8, 2011
Formula Pharmaceuticals featured in BioWorld Today
"Looking for Magic ‘Formula’ in Cancer Maintenance Therapy"
 DOWNLOAD PDF





November 11, 2011
Formula Pharmaceuticals featured in Philadelphia Business Journal
"Duo advances a cancer-fighting Formula"
 DOWNLOAD PDF





November 2010
Formula Pharma Selected As One of the Best 15 Biotech companies On East Coast to Present at BioLife 2010


October 2010
Formula Pharma Receives U.S. Government’s Qualifying Therapeutic Discovery Project (QTDP) Grant